BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MLSC
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210528T120000
DTEND;TZID=America/New_York:20210528T130000
DTSTAMP:20260509T125803
CREATED:20210409T185204Z
LAST-MODIFIED:20210409T185204Z
UID:13683-1622203200-1622206800@www.masslifesciences.com
SUMMARY:Networking and Growth Tips - An Immigrants Experiences and Learnings
DESCRIPTION:In this webinar\, learn how to carve a new path for oneself in a new location. \nAbout this Event \nAdopting to a new land can be both fun and nerve-racking. It is also a chance to meet new people\, leverage skills\, and carve out a new path for oneself. \nThe friends and mentors one meets along the way\, make all the difference to one’s happiness and success. \nIn this webinar\, we will explore the importance of: listening to the radio\, having a mentor(s)\, creating a network of support(s)\, communication in the work place in order to up-skill. \nJoin WA and Rupal Trivedi to explore the lessons she learned as an immigrant to America that enabled her to have a successful STEM career. \n**** \nRupal Trivedi: \nRupal is a Software Development Manager at the Civil Identity divison of IDEMIA. With a career spanning over 20-years\, Rupal has built many innovative software products such as issue drivers’s licenses\, monitor network health and blu-ray players. Rupal immigrated to the United States of America as a high-schooler 30-years ago\, went to the UMass Lowell to get a BSc and MSc in Computer Science\, and now is pursing an MBA from the same alma mater! Check out her LinkedIn here \n*** \nThis seminar is open to everyone interested! \n*Donations will contribute toward the enrichment of women careers and future programs* \n*** \nDate/Time: Friday\, May 28th\, 2021\, 12:00-1:00 PM \nLocation: This is a virtual event \nZoom link will be sent out prior to the event. \n*** \nCorporate sponsorships are available. \nEmail info@womenaccelerators.org for more information.
URL:https://www.masslifesciences.com/event/networking-and-growth-tips-an-immigrants-experiences-and-learnings/
LOCATION:Online\, online
ORGANIZER;CN="Women Accelorators":MAILTO:info@womenaccelerators.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210526T160000
DTEND;TZID=America/New_York:20210526T190000
DTSTAMP:20260509T125803
CREATED:20210510T195552Z
LAST-MODIFIED:20210510T195552Z
UID:13889-1622044800-1622055600@www.masslifesciences.com
SUMMARY:Virtual BioXchange Sponsored By Snthesis
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. This month’s event will be sponsored by Snthesis. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform. \nMore about this month’s sponsor: \nSnthesis\, Inc was founded in 2018 by people who have directly felt the pain of organizing scientific data\, and who have seen researchers struggle with the scale of that data. \nThe Snthesis Bio® platform can automatically convert 1\,000’s of spreadsheets\, ELN & LIMS data\, along with public data sets and 300+ other formats\, into one harmonized knowledge graph. And Search Everything – across formats\, across teams\, and across time. \nSnthesis was created to help realize the future of scientific data management. Leverage a digital transformation to cut data curation time in half – spend more time in analysis and discovery!
URL:https://www.masslifesciences.com/event/virtual-bioxchange-sponsored-by-snthesis/
LOCATION:Online\, online
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210526T150000
DTEND;TZID=America/New_York:20210526T180000
DTSTAMP:20260509T125803
CREATED:20210423T201717Z
LAST-MODIFIED:20210423T201717Z
UID:13802-1622041200-1622052000@www.masslifesciences.com
SUMMARY:MassBio Virtual Career Fair
DESCRIPTION:MassBio is excited to announce our first Virtual Career Fair on May 26th from 3-6pm. If your company is growing and looking to hire\, consider signing up to have a virtual booth at our fair. If you are looking for a new opportunity in the life science field\, this is a great way to meet with many companies in the industry. The event will take place through Brazen- the #1 virtual hiring event and online career fair software\, which will allow job seekers to view open positions and chat one-on-one with candidates in exhibitor “booths.” \nFor exhibitors\, the cost is $500 and allows you to have an unlimited number of booth representatives. You’ll also be able to showcase as many open positions as you’d like. If you are interested in participating as a company exhibitor\, please email Jessica Sousa (jessica.sousa@massbio.org)\, and she will provide you with an invoice and a link to sign up for your Brazen account. \nFor job seekers\, there is not cost.
URL:https://www.masslifesciences.com/event/massbio-virtual-career-fair/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210520T174500
DTEND;TZID=America/New_York:20210520T193000
DTSTAMP:20260509T125803
CREATED:20210511T202331Z
LAST-MODIFIED:20210511T202331Z
UID:13918-1621532700-1621539000@www.masslifesciences.com
SUMMARY:Speed Networking with STEM Professionals
DESCRIPTION:It’s that time of year again! We\, at the Massachusetts Association for Women in Science (MASS AWIS)\, are very excited to host our flagship Speed Networking event. Do not miss this unique opportunity to connect virtually with professionals from various backgrounds in STEM fields. During 15-minute rounds\, you will get the chance to interact with panelists and inquire about their roles\, responsibilities\, and companies. We will be hosting this event on REMO allowing you to have the same experience as an in-person networking event! \nDisclaimer: This is NOT a career fair.\nPlease leave your resumes at home. \nMASS AWIS Members Free | Non-members $5.
URL:https://www.masslifesciences.com/event/speed-networking-with-stem-professionals/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210518T183000
DTEND;TZID=America/New_York:20210518T193000
DTSTAMP:20260509T125803
CREATED:20210409T184813Z
LAST-MODIFIED:20210409T184813Z
UID:13690-1621362600-1621366200@www.masslifesciences.com
SUMMARY:Unsung Research Heroes
DESCRIPTION:MIT Koch Institute trainees and investigators join forces with scientists and engineers in the Robert A. Swanson (1969) Biotechnology Center to disarm cancer through imaging\, bioinformatics\, and high throughput screening. This evening webinar celebrates the unsung heroes of MIT’s cancer research efforts while spotlighting three cancer-fighting innovations. Register to receive Zoom information. \nFeatured Presenters: \nJacqueline Lees\, PhD\,\nProfessor of Biology; Virginia & D.K. Ludwig Professor for Cancer Research; Associate Director\, Koch Institute \nSarah Farrington\, PhD\nCore Facilities Administrator\, Koch Institute \nCharlie Whittaker\, PhD\, Scientific Director\, Barbara K. Ostrom (1978) Bioinformatics Facility\nSandra March-Riera\, PhD\, Research Scientist Bhatia Laboratory\nNiketa Nerurkar\, Research Technician\, Bhatia Laboratory \nJeffrey Kuhn\, PhD\, Scientific Director\, Microscopy Facility\nÖmer Yilmaz\, MD\, PhD\, Eisen and Chang Career Development Professor\, Associate Professor of Biology\nGeorge Eng\, MD\, PhD\, Postdoctoral Fellow\, Yilmaz Laboratory \nJaime Cheah\, PhD\, Scientific Director\, High Throughput Sciences Facility\nChristian Soule\, Lead Automation Engineer\, High Throughput Sciences Facility\nAndre Richters\, PhD\, Research Scientist\, Koehler Laboratory\nNatalie Boehnke\, PhD\, Postdoctoral Fellow\, Hammond Laboratory
URL:https://www.masslifesciences.com/event/unsung-research-heroes/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210518T160000
DTEND;TZID=America/New_York:20210518T173000
DTSTAMP:20260509T125803
CREATED:20210510T200320Z
LAST-MODIFIED:20210510T200338Z
UID:13882-1621353600-1621359000@www.masslifesciences.com
SUMMARY:Biomanufacturing MetroWest
DESCRIPTION:Join the MetroWest Life Sciences Network for a timely session of cross-industry experts and community leaders to discuss the unique advantages of the MetroWest region.\nAbout this event\nThis interactive event includes a panel discussion on the unique advantages of the MetroWest region for biomanufacturing organizations including: \n• a wide variety of available space for facilities of all sizes and levels of complexity \n• a skilled workforce fed by the region’s many colleges and universities \n• a strong ecosystem of local healthcare and life science organizations\, including Sanofi\, Hologic\, Boston Scientific\, and many others \n• a wealth of complementary service providers experienced with the unique needs of life science manufacturing organizations \n• local governments that understand and support the life sciences ecosystem \nThe panel will also discuss the effects of COVID-19 on the global supply chain\, how local biomanufacturing organizations have helped to fill the gaps\, and opportunities the region can offer for organizations looking to onshore their operations. \nOur expert panel of industry and community leaders includes: \n• Lisa McClintock\, Vice President\, General Manager Framingham\, Sanofi Genzyme \n• Travis McCready\, Executive Director & National Practice Leader\, Life Sciences Markets\, JLL \n• Anthony Rotunno\, Founder & Executive Vice Chair\, Lykan Bioscience \n• Kenn Turner\, President & CEO\, Massachusetts Life Sciences Center \nModerated by: Gabriele Brambilla\, Chief Executive Officer\, Alira Health and Chairman\, MetroWest Life Sciences Network
URL:https://www.masslifesciences.com/event/biomanufacturing-metrowest/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210518T100000
DTEND;TZID=America/New_York:20210518T110000
DTSTAMP:20260509T125803
CREATED:20210511T202534Z
LAST-MODIFIED:20210511T202534Z
UID:13843-1621332000-1621335600@www.masslifesciences.com
SUMMARY:Innovation and Digital Transformation in Biopharma: The Path Forward
DESCRIPTION:Spurred by the necessities of the global pandemic\, innovation and digital transformation in the biopharma industry has been massively accelerated. The speed of development and use of new vaccine platforms for COVID-19\, the surge and dependency on data and analytics\, and adoption of new digitally enabled ways of collaborating and partnering have come in stark contrast to historic ways of working. While there are questions around how this will unfold\, there is little doubt that change is well under way with clear competitive advantages. Please join our panel of industry thought leaders who will share experiences\, insights and recommendations on Biopharma’s transformational innovation journey.\nOur Panelists:\n– Kent Leslie\, Global Head of R&D and CSO\, Amylyx Pharmaceuticals\n– Chris Llewellyn\, Senior Partner\, McKinsey & Company\, Global Leader of Digital and Analytics for Life Sciences and Healthcare\n– Glenn Thomas\, CCO\, QMENTA (moderator)
URL:https://www.masslifesciences.com/event/innovation-and-digital-transformation-in-biopharma-the-path-forward/
LOCATION:Online\, online
ORGANIZER;CN="QMENTA":MAILTO:info@qmenta.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210517
DTEND;VALUE=DATE:20210520
DTSTAMP:20260509T125803
CREATED:20200324T154937Z
LAST-MODIFIED:20210111T192618Z
UID:11405-1621209600-1621468799@www.masslifesciences.com
SUMMARY:Statistics 101 and Statistical Quality Control for Biopharmaceuticals (Virtual)
DESCRIPTION:Course Description\nThis course teaches the basic statistical principles\, state-ofthe-art concepts\, advanced tools\, and available techniques for statistical process monitoring\, quality fault detection\, and continues improvements for wide varietyof applications including biomedical and pharmaceutical manufacturing applications. \nInstructors\nDr. Wenzhen Huang (UMass Dartmouth)\, Dr. Bharatendra K Rai (UMass Dartmouth)\, Dr. Seongkyu Yoon (UMass Lowell) \nTarget Audience\nManufacturing Process Engineer\, Quality Engineer\, Research Scientist\, Bioprocess Engineer \nObjective\nAt the completion of this course the participant will be able to: \nDiscuss and describe quality management philosophies\nDiscuss quality improvements with six sigma strategy and DMAIC\nDescribe\, compute\, summarize\, and interpret sample statistics of manufacturing process data\nExplain concepts of sampling\, sampling distribution\, parameter estimation of population\nDesign\, set up\, and use CUSUM and EWMA charts\nUnderstand some recent developments of SPC control chart for specific applications: short run\, autocorrelated process and multivariate processes \nModules\nM1. Intro to 6s\, Deming 14 points\, and statistical quality control\nM2. Introduction to Statistical Basis of Statistical Quality Control\nM3. Statistical Inference: Hypothesis testing and T1/T2 errors\nM4. Control Charts for SPC\, Process Monitoring and Fault Detection\nM5. Enhancements of SPC Charts: CUSUM & EWMA charts\nM6. Quality Characterization\, Process Capabilities\, Gauge R&R\nM7. Multivariate Statistics (PCA)\nM8. Multivariate Control Charts (MSPC): Multivariate Process Monitoring \nRegistration\nCost of attendance is $2\,500; 50% discount for academic and government. Please head over to BlueSnap to complete your registration. Registration deadline is April 30\, 2021. \nContact Information\nFor any question\, please contact bpqc@uml.edu
URL:https://www.masslifesciences.com/event/statistics-101-and-statistical-quality-control-for-biopharmaceuticals/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210505T100000
DTEND;TZID=UTC:20210506T183000
DTSTAMP:20260509T125803
CREATED:20210409T190627Z
LAST-MODIFIED:20210409T190627Z
UID:13618-1620208800-1620325800@www.masslifesciences.com
SUMMARY:GLOBAL CLINICAL TRIALS CONNECT 2021
DESCRIPTION:The 4th Annual Global Clinical Trials Connect 2021 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research\, clinical trials planning and management. \nThe Pharma and Bio-Tech companies are consistently evolving and new clinical studies\, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased\, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies\, new technologies\, effective and quality collaborations to address these issues\, which can cater to the needs of the patient and the industry. \nThis conference intends to focus on the global health and clinical trials around the world. Bioethics\, regulations\, patient recruitment\, site selection\, real-world data\, data integration & Strategy\, outsourcing\, vendor management\, quality (QbD) in Trial Conduct\, risk-based monitoring\, clinical auditing & financial planning and other significant topics that play a key role in clinical trials will be addressed along with innovative sessions on new technologies\, effective and quality collaborations. \nThis program will certainly educate health care scientists on trial design\, operations\, organizing trials\, research computing\, regulatory aspects\, report on clinical trials and gain a better knowledge of the implications of clinical trials in prevention\, diagnosis\, clinical trial-related ethics and disease treatments. \n“The Virtual summit will facilitate an invaluable networking opportunities with Decision makers and Industry experts\, focusing on real case studies and insightful presentations.Bringing in Exciting features like Q&A Sessions with industry experts\, Networking Video Chat\, Polling\, Raise Hand\, Virtual Exhibitor booths with waiting room/tables and virtual chat\, Peer to Peer connect at Social Lounge\, Handout Bags and more giving opportunity to grow and expand your networking throughout the event” \nIt gives us a great pleasure in welcoming you to our whole new Virtual conference 4th Annual Global Clinical Trials Connect 2021. \nKEY HIGHLIGHTS\nPatient Recruitment and Site selection\nInnovative trial designs\nPartnership & Collaboration – Sponsors\, CROs\, Sites and External Vendors\nPatient centric clinical trials\nMaking Patient Engagement a Reality\nNew innovations in Patient Recruitment planning and execution on a clinical trial\nOutsourcing strategies and models\nElectronic Clinical Outcome Assessment and Electronic Patient Reported Outcome\nStreamlined IRT development process\nPharmacovigilance & Clinical Trials\nPost-Clinical Trial closed communities\nHow to future proof your clinical operations\nImplementing Risk Based Monitoring\nStreamlining R&D and lower costs in clinical trials\nAdaptive Trial Model\nClinical Trial Auditing\nReal World Clinical Trial Strategies\nData Quality & Technology\nClinical Data Strategy & Analytics\nElectronic Data Capture (EDC) Systems\nClinical Technology and Driving Innovation\nM-Health\, Wearable and Consumer Technology\nBig-Data\, IoT and Artificial Intelligence in Clinical trials\nBlockchain technology for improving clinical research quality \nWHO SHOULD ATTEND THE CONFERENCE\nThis event is designed for senior level attendees from various companies including Pharmaceutical\, Bio-Tech\, Bio-Pharma\, CRO’s\, Investigative Sites\, Solution provider and Government institutions. \nAttendees includes VPs\, GMs\, Directors\, Heads and Managers of \nClinical Trials\nClinical Study Management\nClinical Operations\nClinical Research\nPatient Organizations\nPatient Recruitment\nOutsourcing\nVendor Management\nSite Management\nSite Monitoring\nClinical Pharmacology\nIT\nClinical Data Management\nEDC\nClinical/Digital Innovation\nClinical Design/Protocol design/ Strategy makers\nClinical Research Sites\nCROs and CMOs\nHospitals/ Associations\nRegulatory affairs
URL:https://www.masslifesciences.com/event/global-clinical-trials-connect-2021/
LOCATION:Online\, online
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210505T100000
DTEND;TZID=Europe/London:20210506T183000
DTSTAMP:20260509T125803
CREATED:20210318T140005Z
LAST-MODIFIED:20210318T140005Z
UID:13571-1620208800-1620325800@www.masslifesciences.com
SUMMARY:4th Annual Digi-Tech Pharma & AI 2021
DESCRIPTION:The 4th Annual Digi-Tech Pharma & AI conference brings with it even more interactive sessions\, expert speakers\, senior professionals and decision makers from leading pharma\, bio-tech and healthcare industry. Meet the decision makers\, benchmark and learn from real-life use cases to drive organizational change and to understand the new cutting-edge technologies and practical solutions. In this 4th edition as we explore the novel technologies and developments reforming pharmaceutical industry\, we also dive deep into the implementation and advances in machine learning\, deep learning\, artificial intelligence\, informatics and data science which has redefined the development of new drugs\, tackle diseases\, improving healthcare and much more. \nThe enhancements in data management and data integration are providing improvements to both the speed and quality of drug discovery and many clinical trial processes. To be in the forefront\, a necessity for partnership and collaboration with healthcare provider is a must for the pharmaceutical companies\, and these partnerships will also lead to massive advances in R&D using artificial intelligence in genomics and precision medicine to develop a deep understanding of the root causes of diseases. \nThe combination of AI\, big data and IoT technologies are creating new innovations\, also other eminent technologies like cloud computing\, augmented reality\, virtual reality and blockchain are being used extensively in the Pharmaceutical industry’s digital transformation. \n“The Virtual summit will facilitate an invaluable networking opportunities with Decision makers and Industry experts\, focusing on real case studies and insightful presentations.Bringing in Exciting features like Q&A Sessions with industry experts\, Networking Video Chat\, Polling\, Raise Hand\, Virtual Exhibitor booths with waiting room/tables and virtual chat\, Peer to Peer connect at Social Lounge\, Handout Bags and more giving opportunity to grow and expand your networking throughout the event” \nIt gives us a great pleasure in welcoming you to our whole new Virtual pharmaceutical technology conference 4th Annual Digi-Tech Pharma & AI 2021. \nKEY HIGHLIGHTS \nReimagining Pharma by Integrating Science and Technology: \nDigital Technology trends in Pharma and Bio-Tech industry\nAdopting AI and Machine Learning to unlock the full potential of Pharma\nHow pharma can integrate into digital health environment\nCollaborative Innovation: Finding the right partners to leverage new technologies in Pharma\nPatient Centred Drug Discovery\nDigital Discovery and Clinical Trials: \nApplying AI to the design of lead compounds for new drugs\nAlgorithms and Models for drug discovery\nAI and ML for Target Identification & Validation in Drug Discovery\nAdvancing Drug Discovery through quantum computing\nGenomics & Drug Discovery\nVirtual and Hybrid Clinical Trials\nR&D Use Cases\nDecoding the Value of Data Science\, Big Data & Informatics: \nImplementation and relevance of FAIR data principles in Pharma R&D\nHarnessing Data Science for Drug Combination Discovery\nAI and Big Data: A powerful combination for future growth\nThe use of AI to make sense of clinical data\nUse of big data for precision medicine\nMulti-omics & clinical data to unlock the power of complex datasets\nIntegration and Visualization of translational Medicine Data\nData & Healthcare Analytics\nReal-World Data & Real-World Evidence: \nThe Growing Importance of Real-World Data\nRWD for clinical research and drug development\nRWE and RWD to support regulatory decision making\nReal?World Data Science to advance Patient Care\nManaging real world data governance\nDigital Health & Future Innovations: \nHealthcare & Medical Technology\nAdoption of IoT in Pharma\nPotential of Cloud Computing in Pharma\nImpact of Digital Health in Pharma\nDigital Health strategy and Patient centric Clinical Trials\nThe convergence of Digital Therapeutics and Pharma in Digital Health\nHow pharma-health collaboration works on innovating drug discovery & patient experience\nBlockchain and AI-based Platform \nWHO SHOULD ATTEND THE CONFERENCE\nPHARMACEUTICAL CONFERENCES 2021\nThis event is designed for senior level attendees from various companies including pharmaceutical\, biotechnological\, biopharmaceutical\, CRO’s\, Diagnostics\, solution provider and government institutions. \nAttendees includes Chief Data Officer\, VPs\, GMs\, Directors\, Heads and Managers of \nDrug Discovery\nDrug Delivery Innovation\nR&D IT\nBig Data Solutions\nAI/ Machine Learning\nCognitive Computing\nDigital innovative strategic planning\nRegulatory and pharmacovigilance\nIT Strategy\nReal-World Data\nReal-World Evidence\nData Management & Analytics\nData Science\nClinical trials and data management\nTranslational informatics\nData storage and analysis\nEnterprise Architecture\nInformation Systems\nContract outsourcing service providers\nDigital Health\nGenomics\nHealthcare IT\nMulti-channel Management
URL:https://www.masslifesciences.com/event/4th-annual-digi-tech-pharma-ai-2021/
LOCATION:Online\, online
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210505T093000
DTEND;TZID=Europe/London:20210506T173000
DTSTAMP:20260509T125803
CREATED:20210119T145008Z
LAST-MODIFIED:20210119T145008Z
UID:13102-1620207000-1620322200@www.masslifesciences.com
SUMMARY:4th Annual Global Clinical Trials Connect 2021 VIRTUAL CONFERENCE & EXPO
DESCRIPTION:The 4th Annual Global Clinical Trials Connect 2021 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research\, clinical trials planning and management. \nThe Pharma and Bio-Tech companies are consistently evolving and new clinical studies\, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased\, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies\, new technologies\, effective and quality collaborations to address these issues\, which can cater to the needs of the patient and the industry. \nThis conference intends to focus on the global health and clinical trials around the world. Bioethics\, regulations\, patient recruitment\, site selection\, real-world data\, data integration & Strategy\, outsourcing\, vendor management\, quality (QbD) in Trial Conduct\, risk-based monitoring\, clinical auditing & financial planning and other significant topics that play a key role in clinical trials will be addressed along with innovative sessions on new technologies\, effective and quality collaborations. This program will certainly educate health care scientists on trial design\, operations\, organizing trials\, research computing\, regulatory aspects\, report on clinical trials and gain a better knowledge of the implications of clinical trials in prevention\, diagnosis\, clinical trial-related ethics and disease treatments. \nThe summit will facilitate an invaluable networking opportunities with decision makers and focus on real case studies\, insightful presentations and round tables. \nIt gives us a great pleasure in welcoming you to the 4th Annual Global Clinical Trials Connect 2021 conference. \nKey Highlights: \n• Patient Recruitment and Site selection\n• Innovative trial designs\n• Partnership & Collaboration – Sponsors\, CROs\, Sites and External Vendors\n• Patient centric clinical trials\n• New innovations in Patient Recruitment planning and execution on a clinical trial\n• Outsourcing strategies and models\n• Electronic Clinical Outcome Assessment and Electronic Patient Reported Outcome\n• Streamlined IRT development process\n• Pharmacovigilance & Clinical Trials\n• Post-Clinical Trial closed communities\n• How to future proof your clinical operations\n• Implementing Risk Based Monitoring\n• Streamlining R&D and lower costs in clinical trials\n• Adaptive Trial Model\n• Clinical Trial Auditing\n• Real World Clinical Trial Strategies\n• Data Quality & Technology\n• Clinical Data Strategy & Analytics\n• Clinical Technology and Driving Innovation\n• M-Health\, Wearable and Consumer Technology\n• Big-Data\, IoT and Artificial Intelligence Technology in Clinical trials\n• Blockchain technology for improving clinical research quality \nWho should attend the conference: \nThis event is designed for senior level attendees from various companies including pharmaceutical\, biotechnological\, biopharmaceutical\, CRO’s\, Diagnostics\, solution provider and government institutions. \nAttendees includes VPs\, GMs\, Directors\, Heads and Managers of: \nClinical Trials\nClinical Study Management\nClinical Operations\nClinical Research\nPatient Organizations\nPatient Recruitment\nOutsourcing\nVendor Management\nSite Management\nSite Monitoring\nClinical Pharmacology\nIT\nClinical Data Management\nEDC\nClinical/Digital Innovation\nClinical Design/Protocol design/ Strategy makers\nClinical Research Sites\nCROs and CMOs\nHospitals/ Associations\nRegulatory affairs
URL:https://www.masslifesciences.com/event/4th-annual-global-clinical-trials-connect-2021-virtual-conference-expo/
LOCATION:Online\, online
ORGANIZER;CN="corvus global events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210503T130000
DTEND;TZID=America/New_York:20210507T150000
DTSTAMP:20260509T125803
CREATED:20210210T202059Z
LAST-MODIFIED:20210210T202059Z
UID:13226-1620046800-1620399600@www.masslifesciences.com
SUMMARY:Presenting With Persuasion\, Clarity & Strength
DESCRIPTION:Discounts for MassBio Member Companies: MassBio Members receive discounts on all of our courses. Check here to see if your company is a MassBio Member. If so\, please contact courses@massbioed.org before registering to receive your coupon code. \nDescription \nThe ability to speak in a clear\, comfortable\, and confident manner is a key skill for all biotech industry professionals. Whether presenting internally to a small group of peers\, entire departments\, management\, or externally to clinicians\, patient advocates\, other medical professionals\, the press\, or investors\, telling your story effectively\, delivering meaningful messages\, being persuasive\, and speaking confidently in a variety of settings takes skill development and practice. The workshop will be interactive\, with practice\, role playing\, and exercises. Combining this approach with a comprehensive agenda ensures participants will gain important\, practical\, lifelong skills that they can put to immediate use. \nSchedule \nMay 3rd\, 2021\, 1:00-2:30 PM EST\nMay 5th\, 2021\, 1:00-2:30 PM EST\nMay 7th\, 2021\, 1:00-3:00 PM EST\nAgenda \nSession 1:\nIntroduction\nSharing Communication Challenges\nUnderstanding the Listener’s Needs\nUnderstanding the Communication Environment\nIdentifying Theme\nOrganizing Content\nBeing Persuasive \nSession 2:\nControlling Nervousness\nUsing Notes\nWorking with Visual Aids\nBest Practices for Presenting Virtually\nHandling Questions \nSession 3:\nPractice Strategies\nDelivering Presentation to Group for feedback and coaching \nInstructor \nRobin Golinski\nExecutive Communication Coach\, Speech Improvement Company\nRobin Golinski is an energetic and accomplished coach and trainer of The Speech Improvement Company. Her intuitive and upbeat personality accentuates her insightful and practical communication skills. \nRobin saw early on the power of storytelling and humor as effective communication tools for influencing and persuading others. Among Robin’s many accomplishments are: co-author of The Handbook of Communication Training\, former Chair of the National Communication Association Training & Development division\, and trainer for Harvard Schools of Medicine\, Design and Engineering. \nRobin has personally been responsible for strengthening the communication prowess of hundreds of researchers\, scientists\, physicians and others in the medical field at renowned companies such as C.R. Bard\, Hologic\, Johnson & Johnson\, Ethicon\, Acclarent\, and DePuySynthes\, Agios\, Scipher Medicine\, Foundation Medicine\, Forrester Research\, RallyBio\, ThriveBio\, DermBiont and Sanofi. \nRobin’s formal education includes a B.S. from Oakland University. She is nationally certified from The Instructor Training Institute\, and has been trained at CTI – The Coaches Training Institute. Robin is also an Infinite Possibilities certified trainer and an active member of the National Communication Association.
URL:https://www.masslifesciences.com/event/presenting-with-persuasion-clarity-strength-3/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210429T183000
DTEND;TZID=America/New_York:20210429T193000
DTSTAMP:20260509T125803
CREATED:20210409T184926Z
LAST-MODIFIED:20210409T184926Z
UID:13689-1619721000-1619724600@www.masslifesciences.com
SUMMARY:A Conversation with the New MIT Koch Institute Director
DESCRIPTION:The Koch Institute at MIT celebrates the appointment of Matthew Vander Heiden as the fifth director of MIT’s NCI-designated cancer research program. A pioneer in cancer metabolism as well as a practicing oncologist\, Dr. Vander Heiden brings deep experience and keen insight to the multi-faceted work of the Koch Institute community. On Thursday\, April 29 he joins MIT President Emerita Susan Hockfield in a virtual conversation about his vision for cancer research at MIT. Register to receive Zoom information.
URL:https://www.masslifesciences.com/event/a-conversation-with-the-new-mit-koch-institute-director/
LOCATION:Online\, online
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210428T160000
DTEND;TZID=America/New_York:20210428T190000
DTSTAMP:20260509T125803
CREATED:20210409T185756Z
LAST-MODIFIED:20210409T185756Z
UID:13658-1619625600-1619636400@www.masslifesciences.com
SUMMARY:BioXchange Sponsored by Bailey Glasser
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. This month’s event will be sponsored by Bailey Glasser. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room.\n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform. \nMore about this month’s sponsor: \nBailey Glasser is a full service law firm with 15 offices throughout the country\, including in Boston. Clients rely on Bailey Glasser to handle the most challenging and consequential legal issues—regionally and nationwide. \nMedical device\, biotech\, pharmaceutical\, and other companies\, and their venture capital\, private equity and financing partners\, turn to Bailey Glasser’s multidisciplinary legal team for strategic legal counsel to help achieve their business objectives. Bailey Glasser’s broad range of innovative clients includes emerging startups\, mid-market companies and global corporations. \nBailey Glasser is also a litigation powerhouse. Its lawyers are equally comfortable and adept in the role of defendant and plaintiff. It brings a trial-focused approach to litigation to vigorously protect the interests of clients. Bailey Glasser represents government and businesses\, as well as individual plaintiffs and defendants\, and professionals and lawyers throughout the country call upon the firm to access its unique blend of resources and trial experience.
URL:https://www.masslifesciences.com/event/bioxchange-sponsored-by-bailey-glasser/
LOCATION:Online\, online
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210421T120000
DTEND;TZID=America/New_York:20210421T130000
DTSTAMP:20260509T125803
CREATED:20210409T185310Z
LAST-MODIFIED:20210409T185310Z
UID:13682-1619006400-1619010000@www.masslifesciences.com
SUMMARY:Creating Confidence with Brenda Loan Baker
DESCRIPTION:In this webinar\, we’ll discuss how to appear credible and confident to significantly raise effectiveness! \nAbout this Event \nLife is rich and full! How does this work? By Creating Confidence! \nImagine how your life might change if you had the skills to show up at your best on purpose\, every time. Whether you are meeting one-on-one with clients\, interacting with colleagues\, or delivering a formal presentation\, appearing credible and confident will significantly raise your effectiveness. \n• Learn the power of executive presence \n• Recognize/Prevent the “tells” of nervousness and intimidation \n• Strike a balance between authority and approachability \n• Demonstrate composure under pressure \n*** \nJoin Brenda Loan Baker as she helps us explore ways to appear credible and confident to significantly raise our effectiveness!! \n*** \n*Donations will contribute toward the enrichment of women careers and future programs* \nThis webinar is for everyone interested\, register today! \n*** \nDate/Time: Wednesday\, April 21st\, 2021\, 12-1 PM \nLink to the webinar will be provided a day before the webinar. \n*** \nPCC Exective and Leadership Coach Brenda Loan Baker serves leaders at all levels and across a broad range of functional roles and industries. She has a special interest in partnering with women and minorities in normally male-dominated industries like STEM\, finance and law\, to help them become more confident\, visible\, and influential leaders. It is Brenda’s passion to assist women and minorities in building greater confidence\, improving their communication and public speaking\, so they can lead with strength and compassion and become a role model for women to follow. Leading them to dream bigger\, achieve their goals with or without a female mentor\, and blaze a path of leadership combining all of their qualities including the feminine one. \n*** \nCorporate Sponsorship opportunities are available. \nEmail info@womenaccelerators.org for more information. \n***
URL:https://www.masslifesciences.com/event/creating-confidence-with-brenda-loan-baker/
LOCATION:Online\, online
ORGANIZER;CN="Women Accelorators":MAILTO:info@womenaccelerators.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210417T133000
DTEND;TZID=America/New_York:20210417T143000
DTSTAMP:20260509T125803
CREATED:20210409T184336Z
LAST-MODIFIED:20210409T184336Z
UID:13692-1618666200-1618669800@www.masslifesciences.com
SUMMARY:MIT Koch Institute Virtual Tours
DESCRIPTION:Cambridge Science Fest 2021: MIT Koch Institute Tours \nWhile the MIT campus is closed\, hop on Zoom to enjoy behind the scenes tours of Koch Institute laboratories led by MIT scientists and engineers. Join researchers at the bench as you explore the tools and technologies of cutting-edge cancer research. Questions encouraged! Visit our webpage to register for some or all events and receive Zoom information. \nUpcoming Tours\nSaturday\, April 17 at 1:30 p.m. – Hemann Laboratory\, led by Kate Koch – explore the tools used to improve CAR-T immunotherapy \nWednesday\, April 21 at 10:00 a.m. – Hemann Laboratory\, led by Kate Koch – explore the tools used to improve CAR-T immunotherapy \nFriday\, April 23 at 12:30 p.m. – Bhatia Lab/Marble Center for Cancer Nanomedicine\, led by Liang Hao – explore nanotechnology for cancer therapeutics
URL:https://www.masslifesciences.com/event/mit-koch-institute-virtual-tours/2021-04-17/
LOCATION:Online\, online
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210415T100000
DTEND;TZID=America/New_York:20210415T110000
DTSTAMP:20260509T125803
CREATED:20210409T185358Z
LAST-MODIFIED:20210409T185358Z
UID:13679-1618480800-1618484400@www.masslifesciences.com
SUMMARY:Neurology Clinical Trials Are Failing. How Can We Fix Them?
DESCRIPTION:One billion people worldwide suffer from neurological related disorders with limited therapy options. Over 2000 neurological clinical trials start each year in the US alone. Yet\, it is estimated that only 5.9% of Phase I neurology drugs are likely to get FDA approval. \nResearch innovation such as new biomarkers or advanced algorithms often do not get translated into clinical practice\, slowing progress. Adding to that\, the scale\, inefficiency and subjectivity of neurological clinical trials makes them inherently difficult. Neuroimaging analysis is key to developing new therapies for brain disease but it’s difficult to do. \nJoin us for a discussion and audience Q&A hosted by QMENTA CEO\, Vesna Prčkovska. Hear from our esteemed panel of experts who work across the life sciences research\, development and care spectrum how clinical research leaders can take key steps now to transform the way they conduct neuroimaging based clinical trials to position them for success. Seats are limited so register now.
URL:https://www.masslifesciences.com/event/neurology-clinical-trials-are-failing-how-can-we-fix-them/
LOCATION:Zoom
ORGANIZER;CN="QMENTA":MAILTO:info@qmenta.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210413T083000
DTEND;TZID=America/New_York:20210413T094500
DTSTAMP:20260509T125803
CREATED:20210318T140830Z
LAST-MODIFIED:20210318T140852Z
UID:13565-1618302600-1618307100@www.masslifesciences.com
SUMMARY:Life Sciences & Sustainability: Exploring Opportunities with Alexandria Real Estate
DESCRIPTION:Scientific research is one of the greatest drivers of the Boston economy – and\, one of the greatest drivers of greenhouse gas emissions. How will laboratory buildings achieve net zero emissions without putting the squeeze on this critical economic engine? Alexandria Real Estate is often considered to be the gold standard for life science development. They are also setting the gold standard for ultra-low emissions laboratory buildings. How are they achieving this impressive goal? \nJoin the BSA\, Rick Malmstrom of Alexandria Real Estate and Jacob Knowles of BR+A for a Client Conversations exploration of their integrated design work that will achieve this goal\, focusing on the under construction\, 500\,000 GSF core-shell lab in Kendall Square that will approach fossil fuel free for space heating.
URL:https://www.masslifesciences.com/event/life-sciences-sustainability-exploring-opportunities-with-alexandria-real-estate/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210412T093000
DTEND;TZID=America/New_York:20210416T110000
DTSTAMP:20260509T125803
CREATED:20210409T185921Z
LAST-MODIFIED:20210409T185935Z
UID:13632-1618219800-1618570800@www.masslifesciences.com
SUMMARY:MassBioEd Career Exploration Week
DESCRIPTION:MassBioEd will be holding a series of 1-hour virtual Career Exploration events with five (5) different life sciences companies or academic institutions during the week of April 12th-16th. Each day\, students will have the chance to hear from professionals working in the industry and experience a virtual lab tour or lab demonstration. Participating companies include: Northeastern University\, MilliporeSigma\, Valo Health\, Arranta Bio\, and Thermo Fisher Scientific. Students\, educators and parents are all welcome to register! \nClick the registration link for more information regarding the event schedule. \nFor questions\, contact Kretsy Mondesir at Kretsy.mondesir@massbioed.org
URL:https://www.masslifesciences.com/event/massbioed-career-exploration-week/2021-04-12/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210409T140000
DTEND;TZID=America/New_York:20210409T160000
DTSTAMP:20260509T125803
CREATED:20210318T141207Z
LAST-MODIFIED:20210318T141207Z
UID:13566-1617976800-1617984000@www.masslifesciences.com
SUMMARY:Virtual Career Fair -Life Science Consortium North Shore
DESCRIPTION:The Life Science Consortium of the North Shore has convened a variety of life science companies ranging in size and technical disciplines\, all with facilities North of Boston. Students and alumnae of the Consortium schools will have the chance to learn about the participating companies from brief presentations on Zoom. Then students can select virtual networking breakout rooms to speak with employers that interest them. In these breakout rooms\, employers can connect with students regarding internship and job opportunities\, and answer questions about their company. This is a free event for both employers and students.
URL:https://www.masslifesciences.com/event/virtual-career-fair-life-science-consortium-north-shore/
LOCATION:Online\, online
ORGANIZER;CN="Life Science Consortium of the North Shore":MAILTO:lynn.sutherland@nsiv.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210408T173000
DTEND;TZID=America/New_York:20210408T190000
DTSTAMP:20260509T125803
CREATED:20210222T124313Z
LAST-MODIFIED:20210222T124313Z
UID:13388-1617903000-1617908400@www.masslifesciences.com
SUMMARY:Science Club for Girls - Virtual Catalyst Awards 2021
DESCRIPTION:Virtual Nonprofit Event\n100% of the proceeds from this event will be donated to Science Club for Girls \nJoin us for an inspiring evening where you’ll hear stories from our community\, see our Science Clubs ‘in action’\, and meet some remarkable women who are paving the way for a more diverse\, inclusive world of STEM. \n5:30 – 6:00 P.M. – Networking\n6:00 – 7:00 P.M. – Main event \nThis year\, we are excited to be honoring Beth Chandler\, CEO of YW Boston\, and Rana el Kaliouby\, Ph.D.\, CEO and Co-Founder of Affectiva as our Catalyst Awardees!
URL:https://www.masslifesciences.com/event/science-club-for-girls-virtual-catalyst-awards-2021/
LOCATION:Online\, online
ORGANIZER;CN="Science Club for Girls":MAILTO:scfg@scienceclubforgirls.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210406T120000
DTEND;TZID=America/New_York:20210406T124500
DTSTAMP:20260509T125803
CREATED:20210222T124407Z
LAST-MODIFIED:20210222T124407Z
UID:13387-1617710400-1617713100@www.masslifesciences.com
SUMMARY:Biopharma R&D During COVID-19: One Year Later
DESCRIPTION:The SARS-CoV-2 pandemic brought new challenges and opportunities to biotech and pharmaceutical companies. Several new vaccines and therapies have already been brought to patients. Companies initiated efforts to catalyze collaborative research\, new ways of working and social justice. One year into the pandemic\, we will examine the initial lessons for biopharma R&D – what worked\, what didn’t\, and how can the industry sustain momentum on emerging priorities for the future? Join Harvard Medical School Executive Education for a discussion with three of the industry’s top leaders. \nSpeakers: \nJay Bradner\, MD\nPresident\, Novartis Institutes for BioMedical Research (NIBR)\nExecutive Committee Member\, Novartis \nAndrew Plump\, MD\, PhD\nPresident\, Research & Development\, Takeda Pharmaceuticals \nMichelle McMurry-Heath\, MD\, PhD\nPresident & CEO\, Biotechnology Innovation Organization (BIO)
URL:https://www.masslifesciences.com/event/biopharma-rd-during-covid-19-one-year-later/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210405T150000
DTEND;TZID=America/New_York:20210409T173000
DTSTAMP:20260509T125803
CREATED:20210203T221220Z
LAST-MODIFIED:20210203T221220Z
UID:13188-1617634800-1617989400@www.masslifesciences.com
SUMMARY:Business of Biotech 201: From Molecule to Market\, R&D and Regulatory Considerations
DESCRIPTION:Discounts for MassBio Member Companies: MassBio Members receive discounts on all of our courses. Check here to see if your company is a MassBio Member. If so\, please contact courses@massbioed.org before registering to receive your coupon code. \nDescription \nThis MassBioEd online course builds on the business overview of “The Business of Biotech 101” course. For those considering careers in the biopharma space or transitioning from the science and technical aspects of the industry\, this course delivers an outline of Clinical\, Regulatory\, and Quality considerations and practices. Students will be provided foundational information about the BioPharma industry and regulations via instruction\, storytelling\, and breakout group discussions. Industry ethics will be discussed\, with emphasis on historical precedents. We will explore the decision-making process by touching on relevant topics such as market share and phases of development. \nGuest speakers will be invited to represent specific considerations and to showcase their roles and experiences. We will review Research and Development processes and considerations from pre-clinical through market approval. \nSchedule \nMonday\, April 5th\, 2021 03:00 PM – 05:30 PM EST\nWednesday\, April 7th\, 2021 03:00 PM – 05:30 PM EST\nFriday\, April 9th\, 2021 03:00 PM – 05:30 PM EST\nAgenda \nSession 1:\nThe History of Regulations\nIndustry Overview\nResearch & Development: An Overview of R&D \nSession 2:\nRoles in Clinical Trials\nMarketing Considerations \nSession 3:\nCompliance via Regulatory & Quality Processes
URL:https://www.masslifesciences.com/event/business-of-biotech-201-from-molecule-to-market-rd-and-regulatory-considerations/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210405T000000
DTEND;TZID=America/New_York:20210430T000000
DTSTAMP:20260509T125803
CREATED:20210127T191328Z
LAST-MODIFIED:20210127T191328Z
UID:13146-1617580800-1619740800@www.masslifesciences.com
SUMMARY:Driving Health Care Strategy in the COVID Era: Business Insights from Inside the Ecosystem
DESCRIPTION:A Harvard Medical School executive education program designed to provide a 360 degree immersion into the forces shaping health care. \nThe coronavirus pandemic has revealed many vulnerabilities within the global health care ecosystem. These challenges present opportunities for companies and health systems to create new value for health care. What strategies should you be developing for the COVID era? Whether you are a seasoned health care executive\, or a business leader looking to move into health care\, this program will prepare you to launch or advance initiatives that create new value in health care. \nHealth care is being transformed by several converging forces including the accelerating growth of machine learning\, genomics and precision medicine\, digital technologies\, changes in reimbursement and a renewed focus on the patient at the center of care. These forces will shape the challenges and opportunities for industry stakeholders across all health care sectors. In order for innovations to succeed and meet important unmet needs of patients\, providers or payers\, business and science leaders need an in-depth understanding of the current health care ecosystem.
URL:https://www.masslifesciences.com/event/driving-health-care-strategy-in-the-covid-era-business-insights-from-inside-the-ecosystem/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210331T120000
DTEND;TZID=America/New_York:20210331T133000
DTSTAMP:20260509T125803
CREATED:20210318T140429Z
LAST-MODIFIED:20210318T140429Z
UID:13570-1617192000-1617197400@www.masslifesciences.com
SUMMARY:How 3D Printing is Reshaping the Future of Health Tech
DESCRIPTION:3D printing has the potential to disrupt how innovators create and providers deliver healthcare solutions\, changing and impacting lives of patients. Join Johnson & Johnson Innovation – JLABS on 3/31 to hear from experts in the field on where they think the future of 3D printing is headed\, advancements that are on the horizon and the future of these printed healthcare solutions.
URL:https://www.masslifesciences.com/event/how-3d-printing-is-reshaping-the-future-of-health-tech/
LOCATION:Virtual Event
ORGANIZER;CN="Johnson & Johnson Innovation":MAILTO:clee22@its.jnj.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210330T093000
DTEND;TZID=America/New_York:20210330T103000
DTSTAMP:20260509T125803
CREATED:20210318T140535Z
LAST-MODIFIED:20210318T140535Z
UID:13567-1617096600-1617100200@www.masslifesciences.com
SUMMARY:Tufts Research Forums 2021: Successes and Challenges of the COVID-19 Vaccine Rollout in the Global Context
DESCRIPTION:Building on the themes that emerged from the Tufts 2020 COVID-19 Research Symposium: Research. Policy. Solutions\, the Office for the Vice Provost for Research will host a series of Research Forums this year. Curated by the COVID-19 Research Steering Committee\, these forums highlight Tufts’ unique niche in the research landscape and its ability to address issues in research equity and health to positively impact our local and global communities. The first topic of the series is Successes and Challenges of the COVID-19 Vaccine Rollout in the Global Context. \nThis event will explore critical issues related to the development and implementation of the COVID-19 vaccination program across the globe. After brief presentations\, the conversation will focus on how to ensure equitable access to the COVID-19 vaccine. \nThe expert panel will include Dr. Salim Abdool Karim\, FRS\, Director of the Centre for the AIDS Program of Research in South Africa\, and Dr. Ramanan Laxminaryanan\, Founder and Director of the Center for Disease Dynamics\, Economics & Policy\, presenting on India. The session will be moderated by Dr. Simone Wildes\, a Tufts Medical Center affiliated Infectious Disease Physician based out of South Shore Hospital and a member of the Massachusetts COVID-19 Vaccine Advisory Group. \nSponsored by the Office for the Vice Provost for Research. \nThis event is open to the public and registration is required. \nIf you have any questions\, please contact covid19research@tufts.edu.
URL:https://www.masslifesciences.com/event/tufts-research-forums-2021-successes-and-challenges-of-the-covid-19-vaccine-rollout-in-the-global-context/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210329T120000
DTEND;TZID=America/New_York:20210329T124500
DTSTAMP:20260509T125803
CREATED:20210222T124519Z
LAST-MODIFIED:20210222T124519Z
UID:13386-1617019200-1617021900@www.masslifesciences.com
SUMMARY:Health Care Leadership During COVID-19
DESCRIPTION:The COVID-19 pandemic has upended health care delivery and economics. This Harvard Medical School Executive Education webinar will provide the behind-the-scenes perspective of a senior hospital leader in a time of crisis. Dr. Kimball will discuss how she and her leadership team adapted to the immediate crisis as well as its prolonged evolution\, from establishing a command structure to discovering hidden talents on their team. The session will explore leadership lessons and her insights for the path forward.
URL:https://www.masslifesciences.com/event/health-care-leadership-during-covid-19/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210329T090000
DTEND;TZID=America/Los_Angeles:20210401T170000
DTSTAMP:20260509T125803
CREATED:20201215T182328Z
LAST-MODIFIED:20201215T182328Z
UID:12877-1617008400-1617296400@www.masslifesciences.com
SUMMARY:Festival of Biologics Usa
DESCRIPTION:The Festival of Biologics is the meeting place for the life science community to bridge the gap between academia and industry. With three events in one across Antibodies\, Immunotherapy and Biosimilars\, the Festival encourages conversation across the entire industry so you can inspire change\, champion innovation\, and address complex challenges that the industry is facing. \nOur mission is to bring together senior biologics professionals across the antibody\, immunotherapy\, and biosimilar value chains to showcase their research\, collaborate on challenges\, forge new connections and ultimately advance the industry to improve patient health.
URL:https://www.masslifesciences.com/event/festival-of-biologics-usa/
LOCATION:Online\, online
ORGANIZER;CN="Terrapinn":MAILTO:bree.vaughn@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210325T120000
DTEND;TZID=America/New_York:20210325T133000
DTSTAMP:20260509T125803
CREATED:20210304T023545Z
LAST-MODIFIED:20210304T023545Z
UID:13475-1616673600-1616679000@www.masslifesciences.com
SUMMARY:WIB-Greater Boston: Sixth Annual Lobster Pot Pitch Event
DESCRIPTION:What better way to honor Women’s History Month than to celebrate powerful women in the life sciences? Come to WIB-Greater Boston’s famous 6th Annual Lobster Pot. \nAs the name suggests\, this event will be in the “shark tank style\,” with each fundraising executive pitching to investors and the audience. The investors will provide feedback on the pitch and comment on the ideas presented. Join us on March 25\, 2021\, to learn how to pitch to investors more effectively\, and to check out some exciting NewCos in the life sciences space. \nSo whether you are starting your own company\, raising money\, or just want to celebrate powerful women\, this is one event that you can’t afford to miss. \nDisclaimer: This event may be recorded. There is a possibility your image and/or voice may be a part of that recording. If you are uncomfortable\, please be sure to turn off your webcam. \nProgram \n12:00 p.m. – 12:05 p.m. Welcome & Event Overview\n12:05 p.m. – 12:10 p.m. Panelist Introductions\n12:10 p.m. – 1:30 p.m. Company Pitches & Investor Feedback \n15 min each (6 min. pitches\, 6 min. feedback\, 1 min. transition\, 2 min. buffer) \n12:10 p.m. – 12:25 p.m. Company 1\n12:25 p.m. – 12:40 p.m. Company 2\n12:40 p.m. – 12:55 p.m. Company 3\n12:55 p.m. – 1:10 p.m. Company 3\n1:10 p.m. – 1:25 p.m. Panel Discussion\, Q&A\n1:25 p.m. – 1:30 p.m. Thanks and Closing Remarks \nSpeakers \nModerator \nMarian Nakada\, Ph.D.\, Vice President\, Venture Investments\, J&J Innovation JJDC \nVC panelists \nLaura Brass\, Ph.D.\, MBA\, Partner\, Novartis Venture Fund\nRuta Laukien\, Graybella Capital\nClaire Leurent\, Johnson & Johnson Innovation \nNewCo Pitches \nErika Smith\, CEO\, ReNetX Bio\, Inc\nElizabeth Gazda\, CEO\, Embrlabs\nMaria Luisa Pineda\, CEO & Co-Founder\, Envisagenics\nNatalie Artzi\, Ph.D. Co-Founder\, BioDevek \nPricing Information \nMembers: Free\nNon-members*: $10\nOptional Donation: $5
URL:https://www.masslifesciences.com/event/wib-greater-boston-sixth-annual-lobster-pot-pitch-event/
LOCATION:Online\, online
ORGANIZER;CN="Women in Bio":MAILTO:info@womeninbio.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210324T170000
DTEND;TZID=America/New_York:20210324T233000
DTSTAMP:20260509T125803
CREATED:20210304T023414Z
LAST-MODIFIED:20210304T023420Z
UID:13485-1616605200-1616628600@www.masslifesciences.com
SUMMARY:2021 M2D2 $200K Challenge Pitch-Off & Awards Celebration
DESCRIPTION:Calling all Investors\, Medical Device Innovators\, Biotech Entrepreneurs\, Academics\, Students\, and Life Sciences Industry Professionals:\nJoin the worldwide life sciences community online as the $200K Challenge finalists selected through a competitive process pitch their innovations virtually to our panel of judges. At stake: a share of a $200\,000 purse of sponsor-provided\, in-kind resources that can help take an innovation to the next level—or even to market! \n(Examples of in-kind resources include lab space\, equipment\, and legal/regulatory guidance) \nWe’ve seen past winners advance to larger funding rounds\, commence clinical studies\, and enter strategic partnerships with global life sciences companies. The $200K Challenge is the place to see what’s up-and-coming in life sciences innovation. \nTICKETS ARE FREE—CHOOSE ONE OR BOTH EVENTS:\nFinalist Pitch-Off — Wednesday\, March 24th @ 5pm ET\nOur 15 Finalists will each have four minutes to make their cases to our panel. \nKEYNOTE SPEAKER: Kenn Turner\, President & CEO of Mass Life Sciences \nAwards Celebration — Wednesday\, April 7th @ 5pm ET\nJoin us for the announcement of the $200K Challenge winners! \nTHANK YOU TO OUR 2021 SPONSORS!
URL:https://www.masslifesciences.com/event/2021-m2d2-200k-challenge-pitch-off-awards-celebration/2021-03-24/
LOCATION:Online\, online
END:VEVENT
END:VCALENDAR